Andrea Park
Fortuna: - $ al 31/05/2026
Fortuna: - $ al 31/05/2026
Ms. Andrea E.
Park was previously employed as a Chief Financial Officer by AlphaTON Capital Corp., a Chief Financial Officer by AgeX Therapeutics, Inc., a Vice President-Finance & Controller by Lineage Cell Therapeutics, Inc., and a Chief Financial & Accounting Officer by Serina Therapeutics, Inc. She received her undergraduate degree from the University of California.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ALPHA COMPUTE CORP -.--% | 21/07/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| ALPHA COMPUTE CORP | Director Financiero/CFO | 24/10/2025 |
| LINEAGE CELL THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/09/2019 |
| AGEX THERAPEUTICS, INC. | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
AlphaTON Capital Corp.
AlphaTON Capital Corp. Packaged SoftwareTechnology Services Operates as an AI compute infrastructure company that provides hardware-enforced GPU as a service solutions | Technology Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AgeX Therapeutics, Inc.
AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.